VRT:NYSE
Vertiv Holdings, LLC
Data as of 2026-03-10 - not real-time
$264.35
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Vertiv Holdings (VRT) is trading well above its 20‑day, 50‑day and 200‑day moving averages at $264.35, indicating a strong bullish trend, but the RSI of 66 hints at near‑term overbought conditions. Technical momentum is mixed: the MACD histogram is negative and the signal line is bearish, while price sits just below the 52‑week high of $266.67 and the identified resistance level of $266.65. Valuation metrics are stretched – the forward PE of 33.5 and trailing PE of 70.9 dwarf the industry average PE of 29.5, and the DCF‑derived fair value of $126.6 suggests a ~44% downside from current levels. The stock exhibits very high volatility (≈84% 30‑day) and a beta of 2.1, underscoring heightened market sensitivity. On the fundamentals side, revenue grew 22.7% YoY, margins remain solid (gross 36%, operating 21%), and ROE is an impressive 41.8%, but leverage is elevated with a debt‑to‑equity of 81.9% and net debt exceeding $1.3 B. Recent news adds momentum: a quarterly dividend was declared, earnings beat expectations, the company was added to the S&P 500, and demand for data‑center infrastructure continues to surge, all supporting a bullish outlook despite the lofty price.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- Price near technical resistance and overbought RSI
- Bearish MACD histogram signaling possible pullback
- Elevated valuation relative to DCF fair value
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Strong earnings beat and accelerating revenue growth
- Inclusion in the S&P 500 boosting institutional demand
- Robust operating margins and high ROE supporting earnings expansion
Long Term
> 3 yearshold
Conviction: 7/10
Key Factors
- Sustainable low‑payout dividend backed by cash generation
- Long‑term data‑center and AI infrastructure tailwinds
- Valuation premium remains a risk despite solid fundamentals
Key Metrics & Analysis
Financial Health
Revenue Growth22.70%
Profit Margin13.03%
P/E Ratio70.9
ROE41.81%
ROA11.12%
Debt/Equity81.90
P/B Ratio25.7
Op. Cash Flow$2.1B
Free Cash Flow$1.4B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI66.5
Support$195.84
Resistance$266.65
MA 20$243.95
MA 50$203.81
MA 200$160.45
MACDBearish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value$126.64
Target Price$263.20
Upside/Downside-0.44%
GradeOvervalued
TypeGrowth
Dividend Yield0.10%
Risk Assessment
Beta2.11
Volatility83.68%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.